ID: ALA5196514

Max Phase: Preclinical

Molecular Formula: C46H56FN7O9S

Molecular Weight: 902.06

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNC(=O)c2c(C)[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c2C)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C46H56FN7O9S/c1-26-36(21-34-33-19-31(47)11-12-35(33)52-42(34)57)51-27(2)39(26)44(59)48-13-14-61-15-16-62-17-18-63-24-38(56)53-41(46(4,5)6)45(60)54-23-32(55)20-37(54)43(58)49-22-29-7-9-30(10-8-29)40-28(3)50-25-64-40/h7-12,19,21,25,32,37,41,51,55H,13-18,20,22-24H2,1-6H3,(H,48,59)(H,49,58)(H,52,57)(H,53,56)/b34-21-/t32-,37+,41-/m1/s1

Standard InChI Key:  GTDUQLRYMOBIGB-NXWMYEPUSA-N

Associated Targets(Human)

HL-60 67320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A498 42825 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/GSPT1 10 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 902.06Molecular Weight (Monoisotopic): 901.3844AlogP: 4.28#Rotatable Bonds: 19
Polar Surface Area: 213.31Molecular Species: NEUTRALHBA: 11HBD: 6
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.38CX Basic pKa: 2.65CX LogP: 2.42CX LogD: 2.42
Aromatic Rings: 4Heavy Atoms: 64QED Weighted: 0.06Np Likeness Score: -0.78

References

1. Zhai J, Li C, Sun B, Wang S, Cui Y, Gao Q, Sang F..  (2022)  Sunitinib-based Proteolysis Targeting Chimeras (PROTACs) reduced the protein levels of FLT-3 and c-KIT in leukemia cell lines.,  78  [PMID:36332882] [10.1016/j.bmcl.2022.129041]

Source